# Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

> **NCT02248402** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chonnam National University Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** Vax-DC/MM

## Key facts

- **NCT ID:** NCT02248402
- **Lead sponsor:** Chonnam National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02248402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02248402, "Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02248402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*